Neuroimaging is a field of biomedical study that uses imaging techniques to investigate brain functions and structure. It is used in many medical fields, such as neurology, psychiatry, and neurosurgery. Neuroimaging techniques provide insight into brain anatomy and activity, which can be used to diagnose and manage a variety of diseases, disorders, and conditions. Neuroimaging can be used to detect changes in brain structure and activity, study the progression of diseases, detect abnormalities, and assess treatment progress. One of the most common neuroimaging techniques is MRI, which utilizes magnets and radio waves to create a three-dimensional image of a patient’s brain. MRI is particularly useful in the diagnosis of stroke, cerebral aneurysm, and other brain conditions or diseases. Other imaging techniques include CT scans, PET and SPECT scans, and fMRI. CT scans utilize X-ray technology to detect changes in brain anatomy, while PET and SPECT scans measure brain activity by showing the size and location of certain substances within the brain. Functional magnetic resonance imaging (fMRI) uses magnetic fields and radio waves to detect changes in blood flow throughout the brain. This technique is most often used to observe how different areas of the brain respond to different tasks. For example, a clinician might want to observe how a patient’s brain responds to a memory task or a language task in order to understand if there is a neurological problem with language or memory. fMRI is also useful in research, as it can be used to study the structure and function of the brain in different conditions or disease states. Neuroimaging is an invaluable tool for the diagnosis and treatment of neurological and psychiatric disorders. By providing detailed images of the brain, it can help doctors identify potential causes of symptoms, as well as the best possible course of treatment. Recent developments in imaging modalities, such as fMRI, have given clinicians and researchers more insight into how the brain works and how certain diseases or conditions affect it.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom